Search results
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 2 hours agoPrior to today's trading, shares of the drugmaker had lost 5.43% over the past month. This...that...
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 13 hours agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 5 days agoBenefits For Regenxbio, Solid But most analysts didn't consider Pfizer a serious competitor. "The...
7,403 Shares in Pfizer Inc. (NYSE:PFE) Bought by Gerber LLC
ETF DAILY NEWS· 2 days agoGerber LLC bought a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,403 shares of the biopharmaceutical ...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 5 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Market Today: Boeing Delays 737 Production, Pfizer Extends Losse
Guru Focus· 4 days agoMarket Performance Overview The S&P 500 and Nasdaq Composite hit fresh record highs this week,...
Best Blue Chip Stocks To Buy in June 2024
GoBankingRates via AOL· 1 day agoBlue chip stocks are among the safest and most secure buys that investors can add to their portfolios. Here are some of the best blue chip stocks to...
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Zacks via Yahoo Finance· 11 hours agoMerck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV...
Moderna stock is lone omen of bird flu pandemic
Reuters· 1 day agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...